Robeco Institutional Asset Management B.V. Acquires 24,941 Shares of Cooper Companies, Inc. (The) (NYSE:COO)

Robeco Institutional Asset Management B.V. increased its position in Cooper Companies, Inc. (The) (NYSE:COO) by 83.3% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 54,888 shares of the medical device company’s stock after acquiring an additional 24,941 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.11% of Cooper Companies, Inc. (The) worth $13,012,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Advisory Services Network LLC raised its holdings in Cooper Companies, Inc. (The) by 30.6% in the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after acquiring an additional 107 shares during the last quarter. YorkBridge Wealth Partners LLC raised its holdings in Cooper Companies, Inc. (The) by 2.1% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after acquiring an additional 11 shares during the last quarter. Acrospire Investment Management LLC grew its position in Cooper Companies, Inc. (The) by 50.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after purchasing an additional 200 shares during the period. Visionary Asset Management Inc. bought a new stake in Cooper Companies, Inc. (The) in the 2nd quarter worth approximately $201,000. Finally, Penserra Capital Management LLC grew its position in Cooper Companies, Inc. (The) by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock worth $211,000 after purchasing an additional 102 shares during the period. Institutional investors own 94.69% of the company’s stock.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Robeco Institutional Asset Management B.V. Acquires 24,941 Shares of Cooper Companies, Inc. (The) (NYSE:COO)” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2017/11/11/cooper-companies-inc-coo-holdings-boosted-by-robeco-institutional-asset-management-b-v.html.

Shares of Cooper Companies, Inc. (COO) traded down $2.89 during trading hours on Friday, reaching $229.06. 341,800 shares of the company traded hands, compared to its average volume of 428,798. The company has a market cap of $11,353.78, a P/E ratio of 24.81, a price-to-earnings-growth ratio of 1.99 and a beta of 0.55. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, beating the consensus estimate of $2.58 by $0.06. The company had revenue of $556.00 million for the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The firm’s revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.30 EPS. analysts predict that Cooper Companies, Inc. will post 9.72 earnings per share for the current fiscal year.

A number of equities research analysts have commented on COO shares. Zacks Investment Research downgraded shares of Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Monday, August 28th. Robert W. Baird reaffirmed a “buy” rating and issued a $267.00 target price (up previously from $251.00) on shares of Cooper Companies, Inc. (The) in a research report on Sunday, September 3rd. KeyCorp reaffirmed a “hold” rating on shares of Cooper Companies, Inc. (The) in a research report on Monday, August 28th. Piper Jaffray Companies lifted their target price on shares of Cooper Companies, Inc. (The) from $265.00 to $280.00 and gave the stock an “overweight” rating in a research report on Friday, September 1st. Finally, Jefferies Group LLC reissued a “buy” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $261.11.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply